Navigation Links
Breast cancer -- combining imaging techniques for quicker and gentler biopsies
Date:11/4/2013

How can you tell if a breast tumor is malignant? This isn't a question that ultrasound and X-rays, or even magnetic resonance scans, can answer alone. Doctors must often extract tissue samples from an affected area with a fine needle for detailed examination. This sort of biopsy is often undertaken with the help of ultrasound, with doctors observing a screen for needle guidance. Unfortunately, around 30 percent of all tumors are invisible to ultrasound. In some cases, magnetic resonance imaging (MRI) is used to ensure correct needle insertion. This process involves two steps: the imaging itself, which takes place inside the MRI scanner, and the insertion of the biopsy needle, for which the patient must be removed from the machine to insert the needle accurately. This process is often repeated several times before the sample is finally taken. This ex-hausts patients and is also costly, because the procedure occupies the MRI scanner for a significant period.

In the joint MARIUS project (Magnetic Resonance Imaging Using Ultrasound systems and processes for multimodal MR imaging), experts from both the Fraunhofer Institute for Biomedical Engineering IBMT in St. Ingbert and the Fraunhofer Institute for Medical Image Computing MEVIS in Bremen are working together towards a quicker and gentler alternative.

Combining imaging techniques intelligently

The new technique would require just one scan of the patient's entire chest at the beginning of the procedure, meaning that the patient only has to enter the scanner once. The subsequent biopsy is guided by ultrasound; the system would transform the initial MRI scan and accurately render it on screen. Doctors would have both the live ultrasound scan and a corresponding MR image available to guide the biopsy needle and display exactly where the tumor is located.

The biggest challenge is that the MRI is performed with the patient lying prone, while during the biopsy she lies on her back. This change of position alters the shape of the patient's breast and shifts the position of the tumor significantly. To track these changes accurately, researchers have applied a clever trick: While the patient is in the MRI chamber during the scan, ultrasound probes, which resemble ECG electrodes, are attached to the patient's skin to provide a succession of ultrasound images. This produces two comparable sets of data from two separate imaging techniques.

When the patient undergoes a biopsy in another examination room, the ultrasound probes remain attached and continually record volume data and track the changes to the shape of the breast. Special algorithms analyze these changes and update the MRI scan accordingly. The MR image changes analogously to the ultrasound scan. When the the biopsy needle is inserted into the breast tissue, the doctor can see the reconciled MRI scan along with the ultrasound image on the screen, greatly improving the accuracy of needle guidance towards the tumor.

Ultrasound equipment suitable for use in an MRI Scanner

To realize this vision, Fraunhofer researchers are developing a range of new components. "We're currently working on an ultrasound device that can be used within an MRI scanner," says IBMT project manager Steffen Tretbar. "These scanners generate strong magnetic fields, and the ultrasound device must work reliably without affecting the MRI scan." Ultrasound probes that can be attached to the body to provide 3D ultrasound imaging are also being developed by the team as part of the project.

The software developed for the technique is also completely new. "We're developing a way to track movements in real time by means of ultrasound tracking," explains MEVIS project manager Matthias Gnther. "This recognizes distended structures in the ultrasound images and tracks their movement. We also need to collate a wide range of sensor data in real time." Some of the sensors gather data about the position and orientation of the attached ultrasound probes while others track the position of the patient.

The team will showcase the entire concept and an initial demonstrator of the technology in November at the MEDICA 2013 trade fair in Dsseldorf at the joint Fraunhofer booth (Hall 10, Booth F05). The next version is set to be completed next year. Whereas the IBMT team is developing the hardware and new ultrasound techniques, the MEVIS working group is concentrating on the software.

The primary objective of MARIUS is to develop ultrasound tracking to aid breast biopsies. Nevertheless, the developed components could also be used in other applications. For instance, the MARIUS system and its movement-tracking software could allow slow imaging techniques such as MRI or positron emission tomography (PET) to accurately track the movements of organs that shift even when a patient is lying still. Aside from the liver and the kidneys, which change shape and position during breathing, this includes the heart, whose contractions also cause motion. Thanks to a technique applied to reconstruct the image, the heart would appear well defined on MRI scans instead of blurred. The jointly developed technology could also be applied to treatments that use particle or X-ray beams. For tumors located in or on a moving organ, the new technology could target the rays so that they follow the movement.These beams could hit the tumor with more precision than currently possible and reduce damage to healthy surrounding tissue.


'/>"/>

Contact: Dipl.-Ing. FH Steffen Tretbar
49-689-498-0226
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related medicine news :

1. Eliminating the good cholesterol receptor may fight breast cancer
2. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Scientists uncover multiple faces of deadly breast cancer
5. Depo-Provera Birth Control Might Raise Breast Cancer Risk
6. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
7. Mayo Clinic launches whole genome breast cancer study
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Teen Drinking May Boost Odds of Precancerous Breast Changes
10. Stress contributes to cognitive declines in women with breast cancer, researcher says
11. Breast Cancer Treatment Side Effects May Last for Years
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast cancer -- combining imaging techniques for quicker and gentler biopsies
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... Delta ... $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired as ... was the American Cancer Society’s 2015 CEO of the Year , helped lead ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show where ... see the most incredible gardens and home improvement experts that attend this amazing show. ... - 700 14th St. Denver CO, is an exciting event that Performance Mobility has ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
(Date:2/7/2016)... Dallas, Texas (PRWEB) , ... February 07, 2016 ... ... its new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and ... , MyDecision™ combines three elements to cut the cost of providing employee healthcare ...
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... Shark ... to announce the launch of a new DRTV campaign with Belly Bands. , Having ... tried everything from sprays to puppy pads and find nothing works, get Belly ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
(Date:2/8/2016)... Feb. 8, 2016 Palatin Technologies, Inc. ... receptor-specific peptide therapeutics for the treatment of diseases ... announced today that the United States Patent and ... Allowance for U.S. Patent Application Serial Number 14/313,258 ... methods of treating female sexual dysfunction using the ...
(Date:2/5/2016)... , Feb. 5, 2016 Amgen (NASDAQ: AMGN ... Annual Global Healthcare Conference at 9:15 a.m. ET on Wednesday, ... . David W. Meline , executive vice president and ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology: